Barclays appoints Jed Brody as Head of Americas Healthcare Banking
October 19 2023 - 11:30AM
Business Wire
Barclays today announces the appointment of Jed Brody as a
Managing Director and Head of Americas Healthcare Banking. Mr.
Brody will be based in New York, and report to Rick Landgarten,
Global Head of Healthcare and Real Estate Investment Banking.
Mr. Brody rejoins Barclays from Leerink Partners (formerly SVB),
where he was a Senior Managing Director. Prior to joining SVB in
2021, Mr. Brody was at Barclays. During his career Mr. Brody has
worked on a number of notable transactions including the sale of
LHC Group to UnitedHealth for $5.4bn, CVS Health’s $69bn
acquisition of Aetna, ICU Medical’s $2.35bn acquisition of Smiths
Medical, the recapitalization of RxBenefits involving Great Hill
Partners and Advent International, and Centene’s $17.3bn
acquisition of WellCare. Mr. Brody has over 20 years of experience
in the industry, and before joining Barclays began his career with
Lehman Brothers.
“We are delighted to welcome Jed back to Barclays. His deep
relationships in the Healthcare industry, together with his
extensive experience in working on complex transactions, will be of
tremendous value to our existing and future clients,” said Rick
Landgarten.
“Jed is a proven leader, and he will play a key role in
strengthening the connectivity between our teams and our clients as
we continue to invest in our Healthcare coverage,” added Taylor
Wright, Global Co-Head of Investment Banking at Barclays.
Other recent hires and appointments in Barclays’ Healthcare
Investment Banking group include Jon Swope being appointed to the
Healthcare Information Technology Banking team, and Maneet Singh
and Evan Matlin being named Co-Heads of M&A Healthcare in the
US. In addition, Jim Birchenough was appointed as Chairman of
Global Healthcare Investment Banking and Co-Head of Global
Biopharma Investment Banking, Alexis de Rosnay as Co-Head of Global
Biopharma Investment Banking and Chairman of Global Healthcare
Investment Banking, and Jeff Ammerman as Global Head of Specialty
Pharmaceuticals Investment Banking.
About Barclays
Barclays is a British universal bank. We are diversified by
business, by different types of customer and client, and geography.
Our businesses include consumer banking and payments operations
around the world, as well as a top-tier, full service, global
corporate and investment bank, all of which are supported by our
service company which provides technology, operations and
functional services across the Group. For further information about
Barclays, please visit our website home.barclays.
About Barclays Corporate and Investment Bank
Barclays Corporate and Investment Bank is comprised of the
Investment Banking, International Corporate Banking, Global Markets
and Research businesses. It provides money managers, financial
institutions, governments, supranational organisations and
corporate clients with services and advice for their funding,
financing, strategic and risk management needs. For further
information about Barclays Corporate and Investment Bank, please
visit our website www.cib.barclays.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231019544165/en/
Andrew Smith 212-412-7521 andrew.x.smith@barclays.com
Barclays (NYSE:BCS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Barclays (NYSE:BCS)
Historical Stock Chart
From Jul 2023 to Jul 2024